Skip to main content
Erschienen in: Clinical & Experimental Metastasis 5/2010

01.05.2010 | Research Paper

Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis

verfasst von: Ryan R. Gordon, Michele La Merrill, Kent W. Hunter, Peter Sørensen, David W. Threadgill, Daniel Pomp

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is a complex disease resulting from a combination of genetic and environmental factors. Among environmental factors, body composition and intake of specific dietary components like total fat are associated with increased incidence of breast cancer and metastasis. We previously showed that mice fed a high-fat diet have shorter mammary cancer latency, increased tumor growth and more pulmonary metastases than mice fed a standard diet. Subsequent genetic analysis identified several modifiers of metastatic mammary cancer along with widespread interactions between cancer modifiers and dietary fat. To elucidate diet-dependent genetic modifiers of mammary cancer and metastasis risk, global gene expression profiles and copy number alterations from mammary cancers were measured and expression quantitative trait loci (eQTL) identified. Functional candidate genes that colocalized with previously detected metastasis modifiers were identified. Additional analyses, such as eQTL by dietary fat interaction analysis, causality and database evaluations, helped to further refine the candidate loci to produce an enriched list of genes potentially involved in the pathogenesis of metastatic mammary cancer.
Literatur
1.
Zurück zum Zitat Rohan TE, Li SQ, Hartwick R, et al. (2006) p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15(7): 1316–1323 Rohan TE, Li SQ, Hartwick R, et al. (2006) p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15(7): 1316–1323
2.
Zurück zum Zitat Song CG, Hu Z, Wu J et al (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 132(10):617–626CrossRefPubMed Song CG, Hu Z, Wu J et al (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 132(10):617–626CrossRefPubMed
3.
Zurück zum Zitat Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA J Am Med Assoc 295(12):1379–1388CrossRef Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA J Am Med Assoc 295(12):1379–1388CrossRef
4.
Zurück zum Zitat Gordon RR, Hunter KW, Sorensen P et al (2008) Genotype X diet interactions in mice predisposed to mammary cancer. I. Body weight and fat. Mamm Genome 19(3):163–178CrossRefPubMed Gordon RR, Hunter KW, Sorensen P et al (2008) Genotype X diet interactions in mice predisposed to mammary cancer. I. Body weight and fat. Mamm Genome 19(3):163–178CrossRefPubMed
5.
Zurück zum Zitat Allan MF, Eisen EJ, Pomp D (2004) The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity. Obes Res 12(9):1397–1407CrossRefPubMed Allan MF, Eisen EJ, Pomp D (2004) The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity. Obes Res 12(9):1397–1407CrossRefPubMed
6.
Zurück zum Zitat Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12(3):954–961PubMed Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12(3):954–961PubMed
7.
Zurück zum Zitat Gordon RR, Hunter KW, La Merrill M et al (2008) Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis. Mamm Genome 19(3):179–189CrossRefPubMed Gordon RR, Hunter KW, La Merrill M et al (2008) Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis. Mamm Genome 19(3):179–189CrossRefPubMed
8.
Zurück zum Zitat La Merrill M, Gordon RR, Hunter KW et al (2010) Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression. Clin Exp Metastasis 27(2):107–116CrossRefPubMed La Merrill M, Gordon RR, Hunter KW et al (2010) Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression. Clin Exp Metastasis 27(2):107–116CrossRefPubMed
9.
Zurück zum Zitat Allan MF, Eisen EJ, Pomp D (2005) Genomic mapping of direct and correlated responses to long-term selection for rapid growth rate in mice. Genetics 170(4):1863–1877CrossRefPubMed Allan MF, Eisen EJ, Pomp D (2005) Genomic mapping of direct and correlated responses to long-term selection for rapid growth rate in mice. Genetics 170(4):1863–1877CrossRefPubMed
10.
Zurück zum Zitat Kuhn K, Baker SC, Chudin E et al (2004) A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res 14(11):2347–2356CrossRefPubMed Kuhn K, Baker SC, Chudin E et al (2004) A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res 14(11):2347–2356CrossRefPubMed
11.
Zurück zum Zitat Du P, Kibbe WA, Lin SM (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24(13):1547–1548CrossRefPubMed Du P, Kibbe WA, Lin SM (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24(13):1547–1548CrossRefPubMed
12.
Zurück zum Zitat Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98(9):5116–5121CrossRefPubMed Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98(9):5116–5121CrossRefPubMed
13.
Zurück zum Zitat Storey JD (2002) A direct approach to false discovery rates. J Roy Stat Soc Ser B 64:479–498CrossRef Storey JD (2002) A direct approach to false discovery rates. J Roy Stat Soc Ser B 64:479–498CrossRef
14.
Zurück zum Zitat Doss S, Schadt EE, Drake TA et al (2005) Cis-acting expression quantitative trait loci in mice. Genome Res 15(5):681–691CrossRefPubMed Doss S, Schadt EE, Drake TA et al (2005) Cis-acting expression quantitative trait loci in mice. Genome Res 15(5):681–691CrossRefPubMed
15.
Zurück zum Zitat Sun W, Yu T, Li KC (2007) Detection of eQTL modules mediated by activity levels of transcription factors. Bioinformatics 23(17):2290–2297CrossRefPubMed Sun W, Yu T, Li KC (2007) Detection of eQTL modules mediated by activity levels of transcription factors. Bioinformatics 23(17):2290–2297CrossRefPubMed
16.
Zurück zum Zitat Rhodes DR, Yu J, Shanker K et al (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1–6PubMed Rhodes DR, Yu J, Shanker K et al (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1–6PubMed
17.
Zurück zum Zitat Crawford NP, Qian X, Ziogas A et al (2007) Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 3(11):e214CrossRefPubMed Crawford NP, Qian X, Ziogas A et al (2007) Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 3(11):e214CrossRefPubMed
18.
Zurück zum Zitat Schadt EE, Lamb J, Yang X et al (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37(7):710–717CrossRefPubMed Schadt EE, Lamb J, Yang X et al (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37(7):710–717CrossRefPubMed
19.
Zurück zum Zitat Eccles SA, Box G, Court W et al (1994) Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophys 24–25:279–291PubMed Eccles SA, Box G, Court W et al (1994) Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophys 24–25:279–291PubMed
20.
Zurück zum Zitat Crawford NP, Walker RC, Lukes L et al (2008) The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis 25(4):357–369CrossRefPubMed Crawford NP, Walker RC, Lukes L et al (2008) The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis 25(4):357–369CrossRefPubMed
21.
Zurück zum Zitat Yamashita S, Wakazono K, Nomoto T et al (2005) Expression quantitative trait loci analysis of 13 genes in the rat prostate. Genetics 171(3):1231–1238CrossRefPubMed Yamashita S, Wakazono K, Nomoto T et al (2005) Expression quantitative trait loci analysis of 13 genes in the rat prostate. Genetics 171(3):1231–1238CrossRefPubMed
22.
Zurück zum Zitat Wang SS, Schadt EE, Wang H et al (2007) Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res 101(3):e11–e30CrossRefPubMed Wang SS, Schadt EE, Wang H et al (2007) Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res 101(3):e11–e30CrossRefPubMed
23.
Zurück zum Zitat Morgan K, Uyuni A, Nandgiri G et al (2008) Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 20(9):843–854CrossRefPubMed Morgan K, Uyuni A, Nandgiri G et al (2008) Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 20(9):843–854CrossRefPubMed
24.
Zurück zum Zitat Gong H, Guo P, Zhai Y et al (2007) Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 21(8):1781–1790 (Baltimore, Md)CrossRefPubMed Gong H, Guo P, Zhai Y et al (2007) Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 21(8):1781–1790 (Baltimore, Md)CrossRefPubMed
25.
Zurück zum Zitat Fraga MF, Ballestar E, Villar-Garea A et al (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37(4):391–400CrossRefPubMed Fraga MF, Ballestar E, Villar-Garea A et al (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37(4):391–400CrossRefPubMed
26.
Zurück zum Zitat Seligson DB, Horvath S, Shi T et al (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435(7046):1262–1266CrossRefPubMed Seligson DB, Horvath S, Shi T et al (2005) Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435(7046):1262–1266CrossRefPubMed
27.
Zurück zum Zitat Liu Y, Tseng M, Perdreau SA et al (2007) Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res 67(6):2685–2692CrossRefPubMed Liu Y, Tseng M, Perdreau SA et al (2007) Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res 67(6):2685–2692CrossRefPubMed
28.
Zurück zum Zitat Lee HS, Park CB, Kim JM et al (2008) Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett 271(1):47–55CrossRefPubMed Lee HS, Park CB, Kim JM et al (2008) Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett 271(1):47–55CrossRefPubMed
29.
Zurück zum Zitat Sieben NL, Oosting J, Flanagan AM et al (2005) Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J Clin Oncol 23(29):7257–7264CrossRefPubMed Sieben NL, Oosting J, Flanagan AM et al (2005) Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J Clin Oncol 23(29):7257–7264CrossRefPubMed
30.
Zurück zum Zitat Chitale D, Gong Y, Taylor BS et al (2009) An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene 28(31):2773–2783CrossRefPubMed Chitale D, Gong Y, Taylor BS et al (2009) An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene 28(31):2773–2783CrossRefPubMed
31.
Zurück zum Zitat Woelfle U, Cloos J, Sauter G et al (2003) Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 63(18):5679–5684PubMed Woelfle U, Cloos J, Sauter G et al (2003) Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 63(18):5679–5684PubMed
32.
Zurück zum Zitat Williams Rt, Lim JE, Harr B et al (2009) A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS ONE 4(3):e4649CrossRefPubMed Williams Rt, Lim JE, Harr B et al (2009) A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS ONE 4(3):e4649CrossRefPubMed
Metadaten
Titel
Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis
verfasst von
Ryan R. Gordon
Michele La Merrill
Kent W. Hunter
Peter Sørensen
David W. Threadgill
Daniel Pomp
Publikationsdatum
01.05.2010
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 5/2010
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9326-z

Weitere Artikel der Ausgabe 5/2010

Clinical & Experimental Metastasis 5/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.